These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34081373)

  • 1. Diffusion tensor imaging reveals greater microstructure damage in lesional tissue that shrinks into cerebrospinal fluid in multiple sclerosis.
    Bergsland N; Dwyer MG; Jakimovski D; Weinstock-Guttman B; Zivadinov R
    J Neuroimaging; 2021 Sep; 31(5):995-1002. PubMed ID: 34081373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis.
    Tavazzi E; Bergsland N; Kuhle J; Jakimovski D; Ramanathan M; Maceski AM; Tomic D; Hagemeier J; Kropshofer H; Leppert D; Dwyer MG; Weinstock-Guttman B; Benedict RHB; Zivadinov R
    J Neurol; 2020 Mar; 267(3):802-811. PubMed ID: 31768628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS.
    Zivadinov R; Horakova D; Bergsland N; Hagemeier J; Ramasamy DP; Uher T; Vaneckova M; Havrdova E; Dwyer MG
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):446-452. PubMed ID: 30819766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis.
    Genovese AV; Hagemeier J; Bergsland N; Jakimovski D; Dwyer MG; Ramasamy DP; Lizarraga AA; Hojnacki D; Kolb C; Weinstock-Guttman B; Zivadinov R
    Radiology; 2019 Nov; 293(2):424-433. PubMed ID: 31549947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation.
    Jakimovski D; Qureshi F; Ramanathan M; Jalaleddini K; Ghoreyshi A; Dwyer MG; Bergsland N; Weinstock-Guttman B; Zivadinov R
    J Neurol Sci; 2024 Jun; 461():123055. PubMed ID: 38761669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis.
    Dwyer MG; Bergsland N; Ramasamy DP; Jakimovski D; Weinstock-Guttman B; Zivadinov R
    J Neuroimaging; 2018 Sep; 28(5):490-495. PubMed ID: 29856910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study.
    Klistorner A; Wang C; Yiannikas C; Parratt J; Dwyer M; Barton J; Graham SL; You Y; Liu S; Barnett MH
    Neuroimage Clin; 2018; 17():1028-1035. PubMed ID: 29387524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choroid plexus enlargement is associated with future periventricular neurodegeneration in multiple sclerosis.
    Bergsland N; Dwyer MG; Jakimovski D; Tavazzi E; Weinstock-Guttman B; Zivadinov R
    Mult Scler Relat Disord; 2024 Jul; 87():105668. PubMed ID: 38744032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of T2 lesion-based disease activity volume outcomes in predicting disease progression in multiple sclerosis over 10 years.
    Oship D; Jakimovski D; Bergsland N; Horakova D; Uher T; Vaneckova M; Havrdova E; Dwyer MG; Zivadinov R
    Mult Scler Relat Disord; 2022 Nov; 67():104187. PubMed ID: 36150263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study.
    Barnett M; Bergsland N; Weinstock-Guttman B; Butzkueven H; Kalincik T; Desmond P; Gaillard F; van Pesch V; Ozakbas S; Rojas JI; Boz C; Altintas A; Wang C; Dwyer MG; Yang S; Jakimovski D; Kyle K; Ramasamy DP; Zivadinov R
    Neuroimage Clin; 2021; 32():102802. PubMed ID: 34469848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1/T2 ratio: A quantitative sensitive marker of brain tissue integrity in multiple sclerosis.
    Hannoun S; Kocevar G; Codjia P; Barile B; Cotton F; Durand-Dubief F; Sappey-Marinier D
    J Neuroimaging; 2022 Mar; 32(2):328-336. PubMed ID: 34752685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Choroid Plexus Inflammation on MRI With Clinical Disability Progression Over 5 Years in Patients With Multiple Sclerosis.
    Bergsland N; Dwyer MG; Jakimovski D; Tavazzi E; Benedict RHB; Weinstock-Guttman B; Zivadinov R
    Neurology; 2023 Feb; 100(9):e911-e920. PubMed ID: 36543575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study.
    Zivadinov R; Pei J; Clayton D; Goldman DE; Winger RC; Cabatingan MS; Dwyer MG; Bergsland N
    J Neurol Neurosurg Psychiatry; 2024 May; 95(6):536-543. PubMed ID: 38071574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative overview of multi-shell diffusion MRI models to characterize the microstructure of multiple sclerosis lesions and periplaques.
    Vanden Bulcke C; Stölting A; Maric D; Macq B; Absinta M; Maggi P
    Neuroimage Clin; 2024; 42():103593. PubMed ID: 38520830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the genetic contribution to brain magnetic resonance imaging lesion load and atrophy measures in multiple sclerosis patients.
    Clarelli F; Assunta Rocca M; Santoro S; De Meo E; Ferrè L; Sorosina M; Martinelli Boneschi F; Esposito F; Filippi M
    Eur J Neurol; 2021 Aug; 28(8):2513-2522. PubMed ID: 33864731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor imaging and disability progression in multiple sclerosis: A 4-year follow-up study.
    Kolasa M; Hakulinen U; Brander A; Hagman S; Dastidar P; Elovaara I; Sumelahti ML
    Brain Behav; 2019 Jan; 9(1):e01194. PubMed ID: 30588771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
    Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-lesional cerebellar damage in patients with clinically isolated syndrome: DTI measures predict
    Kugler AV; Deppe M
    Neuroimage Clin; 2018; 19():633-639. PubMed ID: 29984171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.